阿布昔替尼治疗皮肤扁平苔藓二例并文献复习

doi:10.12144/zgmfskin202406412

Abstract

Abstract: Conventional treatment of lichen planus includes oral glucocorticosteroids, methotrexate, and Acitretin. The use of these drugs is often limited by their adverse effects. JAK inhibitors regulate immunity by inhibiting the JAK-STAT pathway and affecting the function of cytokines such as INF-γ. In this paper, we report two cases of effective cutaneous lichen planus treated with JAK1 inhibitor abrocitinib and review the relevant literature.

Key words: abrocitinib')">">abrocitinib, cutaneous lichen planus, JAK inhibitors

CUI Yinling, XU Fanli, CAO Shan, XUE Xiaotong, ZHAO Qing, LIU Yongxia, LIU Hong, ZHANG Furen. Abrocitinib in the treatment of cutaneous lichen planus: two cases and literature review[J].China Journal of Leprosy and Skin Diseases, 2024, 40(6): 412-415.

0
/ / Recommend abrocitinib; cutaneous lichen planus; JAK inhibitors”. Please open it by linking:http://www.zgmfskin.com/EN/abstract/abstract12307.shtml" name="neirong"> abrocitinib; cutaneous lichen planus; JAK inhibitors">

Add to citation manager EndNote|Reference Manager|ProCite|BibTeX|RefWorks

URL: http://www.zgmfskin.com/EN/10.12144/zgmfskin202406412

http://www.zgmfskin.com/EN/Y2024/V40/I6/412

[1]	ZHU Li, ZHAO Qing, WANG Na, RAN Delin, YANG Baoqi, LIU Yongxia, LIU Hong, ZHANG Furen. Toxic epidermal necrolysis caused by osimertinib and literature review [J]. China Journal of Leprosy and Skin Diseases, 2024, 40(6): 396-401.
[2]	ZHENG Chunzhi, ZHANG Minkuo, SAI Wenwen, CAO Yuanyuan, ZHANG Zhaoxia, PAN Futang, YANG Baoqi, LIU Hong. Bullous pemphigoid occurred after long-term treatment with camrelizumab in a patient with oesophageal cancer: a case report [J]. China Journal of Leprosy and Skin Diseases, 2024, 40(6): 422-424.
[3]	WANG Jianwen, CHEN Xuechao, ZHOU Guizhi, CHEN Shengli, LU Xianmei, ZHANG Xueyan, ZHANG Fan, LIU Yongxia. Clinical and histopathological characters of 28 cases of subungual melanoma [J]. China Journal of Leprosy and Skin Diseases, 2024, 40(3): 182-185.
[4]	HAN Jinghong, LIU Hong. Two children with refractory atopic dermatitis successfully treated with Janus kinase inhibitors [J]. China Journal of Leprosy and Skin Diseases, 2024, 40(3): 190-192.
[5]	LU Yu, JIANG Dong, YANG Dengke, HU Siyuan, YUAN Dezheng, ZHOU Xiaomei, QIN Jianping, GE Jinhong, ZHANG Fengrui, LI Wenyao, GUO Yiyu. Adalimumab for the treatment of perifolliculitis capitis abscedens et suffodiens: a case report [J]. China Journal of Leprosy and Skin Diseases, 2024, 40(3): 210-211.
[6]	LIU Yan, LIU Mengmeng, LIU Yongxia, LU Xianmei, LIU Guoyan. Generalized fibrous hamartoma in infants: a case report [J]. China Journal of Leprosy and Skin Diseases, 2024, 40(3): 212-214.
[7]	XIONG Fei, CAO Jingjiang. Orf: a case report [J]. China Journal of Leprosy and Skin Diseases, 2024, 40(3): 214-215.
[8]	JIAO Yuzhu, YANG Qing. Update of treatment of pyoderma gangrenosum [J]. China Journal of Leprosy and Skin Diseases, 2024, 40(3): 216-220.
[9]	ZHANG Ying, NIU Xuping. Update of targeted treatment of pemphigus [J]. China Journal of Leprosy and Skin Diseases, 2024, 40(3): 221-224.
[10]	MAO Chong, XIONG Junhao. The past and present of leprosy treatment [J]. China Journal of Leprosy and Skin Diseases, 2024, 40(3): 225-228.
[11]	BI Zhaohua, XIE Kai, LIU Guoyan, CHEN Shengli, GUO Xuan. Mohs microsurgery in treatment of eccrine porocarcinoma [J]. China Journal of Leprosy and Skin Diseases, 2024, 40(2): 113-115.
[12]	QU Peng, DU Donghong, YANG Baoqi. Omalizumab in the treatment of childhood solar urticaria: a case report and literature review [J]. China Journal of Leprosy and Skin Diseases, 2024, 40(2): 116-117.
[13]	ZHANG Ting, CAO Yu. Nodular melanoma misdiagnosed as trichoblastoma: a case report [J]. China Journal of Leprosy and Skin Diseases, 2024, 40(2): 118-121.
[14]	JIANG Jiahong, GAO Lina, GU Ankang, ZHANG Jun, GUO Haixia. Eccrine porocarcinoma: three cases report [J]. China Journal of Leprosy and Skin Diseases, 2024, 40(2): 121-124.
[15]	HU Mingyu, XU Weiwei, ZHOU Pengpeng, TANG Junting. Erythema elevatum diutinum associated with multiple systemic damage: a case report [J]. China Journal of Leprosy and Skin Diseases, 2024, 40(2): 124-126.

Abrocitinib in the treatment of cutaneous lichen planus: two cases and literature review

PDF (PC)

Like

Knowledge

Abstract

Cite this article

share this article

References

Related Articles 15

Metrics

Comments

Recommended 10